ClinicalTrials.gov lists 1 registered trial of GHK-Cu: 1 recruiting or about to, 0 running, 0 completed. Recruiting sites are in China. The largest is Topical GHK-Cu Gel for Acute Skin Wound Healing (60 people).
This study will evaluate whether a topical gel containing GHK-Cu (a copper(II)-peptide complex) can safely speed up healing of small, standardized skin wounds in healthy adults compared with a matching vehicle gel.
Participants will receive two small punch-biopsy wounds on the upper arm; each wound will be randomly assigned to receive GHK-Cu gel or vehicle gel under identical dressings. Wounds will be photographed and assessed over 3 weeks, with a follow-up visit to evaluate scar quality.
Registered trials include ones that haven't published results yet. Trials are matched on the compound's name and code names (GHK-Cu, copper peptide, GHK copper) in the listed interventions.